ロード中...
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions
Rapamycin, an inhibitor of mTOR activity, is a potent inducer of erythroid differentiation and fetal hemoglobin production in β-thalassemic patients. Mithramycin (MTH) was studied to see if this inducer of K562 differentiation also operates through inhibition of mTOR. We can conclude from the study...
保存先:
| 出版年: | Pharmacol Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Academic Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309890/ https://ncbi.nlm.nih.gov/pubmed/25478892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2014.11.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|